Rating Change
BTIG analysts reiterated a Buy rating on Rapport Therapeutics, Inc. Common Stock (NASDAQ:RAPP) on August 05, 2026.
reiterateNASDAQ:RAPP
BTIG Reiterates Buy Rating on Rapport Therapeutics, Inc. Common Stock (RAPP)
Rating Change BTIG analysts reiterated a Buy rating on Rapport Therapeutics, Inc. Common Stock (NASDAQ:RAPP) on August 05, 2026. Market Context Rapport Therapeutics, Inc.
Market Context
Rapport Therapeutics, Inc. Common Stock operates in the Healthcare sector. The stock currently trades at $42.44 with a market capitalization of $1.1B.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Rapport Therapeutics, Inc. Common Stock.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Rapport Therapeutics, Inc. Common Stock
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 05, 2026 | BTIG | Buy | N/A |
| Jul 16, 2026 | BTIG | Buy | N/A |
| Jun 24, 2026 | Leerink Partners | Outperform | N/A |
| May 21, 2026 | BTIG | Buy | N/A |
| May 08, 2026 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View RAPP Stock Page
Frequently Asked Questions
What does a Buy rating mean for RAPP?
A Buy rating from BTIG reflects the analyst's outlook on Rapport Therapeutics, Inc. Common Stock (NASDAQ:RAPP). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the RAPP forecast page.